Région de Bruxelles-Capitale < Région de Kantō < Région du Kansai

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 96.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000037 (2020)	Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]	Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
000042 (2020)	Mitsuhiro Akiyama [Japon] ; Yuko Kaneko [Japon] ; Tsutomu Takeuchi [Japon]	Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review.
000056 (2020)	Muneyoshi Futami [Japon] ; Keisuke Suzuki [Japon] ; Satomi Kato [Japon] ; Saori Ohmae [Japon] ; Yoshio Tahara [Japon] ; Masanori Nojima [Japon] ; Yoichi Imai [Japon] ; Takayuki Mimura [Japon] ; Yoshihiro Watanabe [Japon] ; Arinobu Tojo [Japon]	The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells.
000093 (2020)	Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]	Response to: 'Some concerns from Turkey' by Bilgin et al.
000094 (2020)	Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]	Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.
000103 (2020)	Nanase Honda [Japon] ; Naoto Yokogawa [Japon] ; Tomohiro Koga ; Yushiro Endo ; Shiro Matsubara [Japon]	Protracted Febrile Myalgia Syndrome Treated With Tocilizumab.
000124 (2020)	Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]	Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000180 (2020)	Josef S. Smolen [Autriche] ; Robert B M. Landewé [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Andreas Kerschbaumer [Autriche] ; Iain B. Mcinnes [Royaume-Uni] ; Alexandre Sepriano [Pays-Bas] ; Ronald F. Van Vollenhoven [Pays-Bas] ; Maarten De Wit [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; John Askling [Suède] ; Alejandro Balsa [Espagne] ; Maarten Boers [Pays-Bas] ; Alfons A. Den Broeder [Pays-Bas] ; Maya H. Buch [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Roberto Caporali [Italie] ; Mario Humberto Cardiel [Mexique] ; Diederik De Cock [Belgique] ; Catalin Codreanu [Roumanie] ; Maurizio Cutolo [Italie] ; Christopher John Edwards [Royaume-Uni] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Royaume-Uni] ; Axel Finckh [Suisse] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Merete Lund Hetland [Danemark] ; Tom W J. Huizinga [Pays-Bas] ; Marios Koloumas [Suisse] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Ulf Müller-Ladner [Allemagne] ; Eduardo F. Mysler [Argentine] ; Jose A P. Da Silva [Portugal] ; Gyula Po R [Hongrie] ; Janet E. Pope [Canada] ; Andrea Rubbert-Roth [Suisse] ; Adeline Ruyssen-Witrand [France] ; Kenneth G. Saag [États-Unis] ; Anja Strangfeld [Allemagne] ; Tsutomu Takeuchi [Japon] ; Marieke Voshaar [Pays-Bas] ; René Westhovens [Belgique] ; Désirée Van Der Heijde [Pays-Bas]	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
000219 (2020)	Hiroki Yamada [Japon] ; Yuko Kaneko [Japon] ; Hiroya Tamai [Japon] ; Tsutomu Takeuchi [Japon]	Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab.
000267 (2019)	Michitaro Hayakawa [Japon] ; Keisuke Izumi [Japon] ; Misako Higashida-Konishi [Japon] ; Mari Ushikubo [Japon] ; Masako Tsukamoto [Japon] ; Kumiko Akiya [Japon] ; Kazuhiro Araki [Japon] ; Hisaji Oshima [Japon]	Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.
000290 (2019)	Kazutoshi Ebisawa [Japon] ; Yosuke Masamoto [Japon] ; Junji Tokushige [Japon] ; Hiroshi Nishi [Japon] ; Kenjiro Honda [Japon] ; Munetoshi Hinata [Japon] ; Kazuhiro Toyama [Japon] ; Masaomi Nangaku [Japon] ; Mineo Kurokawa [Japon]	Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.
000292 (2019)	Jumpei Saito ; Naho Yakuwa ; Kayoko Kaneko [Japon] ; Chinatsu Takai ; Mikako Goto ; Ken Nakajima ; Akimasa Yamatani ; Atsuko Murashima	Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.
000342 (2019)	Arata Nakajima [Japon] ; Keiichiro Terayama [Japon] ; Masato Sonobe [Japon] ; Yasuchika Aoki [Japon] ; Hiroshi Takahashi [Japon] ; Yorikazu Akatsu [Japon] ; Junya Saito [Japon] ; Shinji Taniguchi [Japon] ; Manabu Yamada [Japon] ; Ayako Kubota [Japon] ; Koichi Nakagawa [Japon]	Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis.
000362 (2019)	Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]	Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.
000413 (2019)	Masayoshi Harigai [Japon] ; Michi Tsutsumino [Japon] ; Hideto Takada [Japon] ; Kenji Nagasaka [Japon]	Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis.
000464 (2019)	Tomohisa Uchida ; Momoko Okamoto ; Keita Fujikawa ; Daisuke Yoshikawa ; Akinari Mizokami ; Tomo Mihara ; Akira Kondo ; Kazuo Ohba ; Kazuhiro Kurohama ; Masahiro Nakashima ; Ichiro Sekine ; Shigeki Nakamura [Japon] ; Yoshitsugu Miyazaki [Japon] ; Atsushi Kawakami [Japon]	Gastric mucormycosis complicated by a gastropleural fistula: A case report and review of the literature.
000509 (2019)	Shuji Asai [Japon] ; Masatoshi Hayashi [Japon] ; Masahiro Hanabayashi [Japon] ; Yasuhide Kanayama [Japon] ; Toki Takemoto [Japon] ; Yuichiro Yabe [Japon] ; Tomone Shioura [Japon] ; Hisato Ishikawa [Japon] ; Yutaka Yoshioka [Japon] ; Takefumi Kato [Japon] ; Yuji Hirano [Japon] ; Takayoshi Fujibayashi [Japon] ; Yosuke Hattori [Japon] ; Tomonori Kobayakawa [Japon] ; Masahiko Ando [Japon] ; Yachiyo Kuwatsuka [Japon] ; Nobunori Takahashi [Japon] ; Takuya Matsumoto [Japon] ; Nobuyuki Asai [Japon] ; Yasumori Sobue [Japon] ; Tsuyoshi Nishiume [Japon] ; Mochihito Suzuki [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]	Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
000545 (2019)	Jumpei Saito [Japon] ; Naho Yakuwa [Japon] ; Kayoko Kaneko [Japon] ; Ken Nakajima [Japon] ; Chinatsu Takai [Japon] ; Mikako Goto [Japon] ; Akimasa Yamatani [Japon] ; Atsuko Murashima [Japon]	Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis.
000547 (2019)	Hiroaki Matsuno [Japon] ; Kou Katayama [Japon] ; Keiko Funahashi [Japon] ; Makoto Saitoh [Japon] ; Tsukasa Matsubara [Japon]	Choice of the most appropriate biological disease-modifying rheumatic drug for injection spacing: results from a multicentre observational study.
000563 (2019)	Manabu Araki [Japon]	Blockade of IL-6 signaling in neuromyelitis optica.
000640 (2018)	Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonoti Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]	Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegion.i -k "Région de Kantō" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegion.i  \
                -Sk "Région de Kantō" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegion.i
   |clé=    Région de Kantō
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021